Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886017639> ?p ?o ?g. }
- W2886017639 endingPage "2496" @default.
- W2886017639 startingPage "2485" @default.
- W2886017639 abstract "Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study Gisèle Pickering,1,2 Nicolas Macian,2 Noémie Delage,3 Pascale Picard,3 Jean-Michel Cardot,4 Sophia Sickout-Arondo,2 Fatiha Giron,2 Christian Dualé,2 Bruno Pereira,5 Fabienne Marcaillou3 1University Clermont Auvergne Neurodol, Clermont-Ferrand, France; 2Clinical Pharmacology Department CPC/CIC Inserm 1405, University Hospital, Clermont-Ferrand, France; 3Pain Clinic, CHU Clermont-Ferrand, Clermont-Ferrand, France; 4University Clermont Auvergne MEDIS, CHU Clermont-Ferrand, Clermont-Ferrand, France; 5DRCI, CHU Clermont-Ferrand, Clermont-Ferrand, France Introduction: Fibromyalgia is characterized by widespread and chronic pain, and its prevalence is increasing worldwide. Milnacipran, an antidepressant, is often prescribed for fibromyalgia with a possible beneficial effect on central pain modulation. The aim of this study was to evaluate if milnacipran could modify the status of conditioned pain modulation (CPM) in patients suffering from fibromyalgia.Design and setting: Randomized, double-blind controlled trial.Subjects and methods: Women with fibromyalgia received milnacipran 100 mg or placebo. The primary end point was the evolution of CPM with treatments after a 30-second painful stimulus. Secondary outcomes included the predictability of milnacipran efficacy from CPM performance, evolution of global pain, mechanical sensitivity, thermal pain threshold, mechanical allodynia, cognitive function, and tolerance.Results: Fifty-four women with fibromyalgia (46.7±10.6 years) were included and randomized, and 24 patients were analyzed in each group. At inclusion, CPM was dysfunctional (CPM30=-0.5±1.9), and global pain was 6.5±1.8. After treatment, there was a nonsignificant CPM difference between milnacipran and placebo (CPM30=-0.46±1.22 vs -0.69±1.43, respectively, p=0.55) and 18.8% vs 6.3% (p=0.085) patients did reactivate CPM after milnacipran vs placebo. Initial CPM was not a predictor of milnacipran efficacy. Global pain, mechanical and thermal thresholds, allodynia, cognition, and tolerance were not significantly different between both groups.Conclusion: Milnacipran did not display a significant analgesic effect after 1-month treatment, but the tendency of milnacipran to reactivate CPM in a number of patients must be explored with longer treatment duration in future studies and pleads for possible subtypes of fibromyalgia patients. Keywords: fibromyalgia, CPM, milnacipran, antidepressants, pain" @default.
- W2886017639 created "2018-08-22" @default.
- W2886017639 creator A5003983768 @default.
- W2886017639 creator A5010795152 @default.
- W2886017639 creator A5013394355 @default.
- W2886017639 creator A5029686578 @default.
- W2886017639 creator A5036480804 @default.
- W2886017639 creator A5044069348 @default.
- W2886017639 creator A5045576370 @default.
- W2886017639 creator A5061765670 @default.
- W2886017639 creator A5063697285 @default.
- W2886017639 creator A5087185601 @default.
- W2886017639 date "2018-08-01" @default.
- W2886017639 modified "2023-10-14" @default.
- W2886017639 title "Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study" @default.
- W2886017639 cites W1495135499 @default.
- W2886017639 cites W1774387537 @default.
- W2886017639 cites W1817261750 @default.
- W2886017639 cites W188184538 @default.
- W2886017639 cites W1955494979 @default.
- W2886017639 cites W1966628524 @default.
- W2886017639 cites W1972958276 @default.
- W2886017639 cites W1973805158 @default.
- W2886017639 cites W1979212730 @default.
- W2886017639 cites W1985927644 @default.
- W2886017639 cites W2003083222 @default.
- W2886017639 cites W2003290433 @default.
- W2886017639 cites W2003627673 @default.
- W2886017639 cites W2009837610 @default.
- W2886017639 cites W2009928888 @default.
- W2886017639 cites W2017258109 @default.
- W2886017639 cites W2024269125 @default.
- W2886017639 cites W2026544265 @default.
- W2886017639 cites W2028204969 @default.
- W2886017639 cites W2032867586 @default.
- W2886017639 cites W2033577846 @default.
- W2886017639 cites W2034182822 @default.
- W2886017639 cites W2047469028 @default.
- W2886017639 cites W2049056319 @default.
- W2886017639 cites W2050505501 @default.
- W2886017639 cites W2059810347 @default.
- W2886017639 cites W2061623382 @default.
- W2886017639 cites W2062700118 @default.
- W2886017639 cites W2068512721 @default.
- W2886017639 cites W2092344668 @default.
- W2886017639 cites W2100251061 @default.
- W2886017639 cites W2101464778 @default.
- W2886017639 cites W2111525124 @default.
- W2886017639 cites W2114506839 @default.
- W2886017639 cites W2122186552 @default.
- W2886017639 cites W2124623574 @default.
- W2886017639 cites W2126031030 @default.
- W2886017639 cites W2128447164 @default.
- W2886017639 cites W2133915381 @default.
- W2886017639 cites W2144915944 @default.
- W2886017639 cites W2149444223 @default.
- W2886017639 cites W2151011975 @default.
- W2886017639 cites W2156551648 @default.
- W2886017639 cites W2160149562 @default.
- W2886017639 cites W2169358051 @default.
- W2886017639 cites W2241822774 @default.
- W2886017639 cites W2265275109 @default.
- W2886017639 cites W2287282505 @default.
- W2886017639 cites W2309345623 @default.
- W2886017639 cites W2312930345 @default.
- W2886017639 cites W2339767472 @default.
- W2886017639 cites W2344135956 @default.
- W2886017639 cites W2411668251 @default.
- W2886017639 cites W2488298563 @default.
- W2886017639 cites W2519579571 @default.
- W2886017639 cites W2557387570 @default.
- W2886017639 cites W2589184080 @default.
- W2886017639 cites W2591514089 @default.
- W2886017639 cites W2592931040 @default.
- W2886017639 cites W2604517073 @default.
- W2886017639 cites W4211169104 @default.
- W2886017639 doi "https://doi.org/10.2147/dddt.s162810" @default.
- W2886017639 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6089099" @default.
- W2886017639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30127596" @default.
- W2886017639 hasPublicationYear "2018" @default.
- W2886017639 type Work @default.
- W2886017639 sameAs 2886017639 @default.
- W2886017639 citedByCount "17" @default.
- W2886017639 countsByYear W28860176392019 @default.
- W2886017639 countsByYear W28860176392020 @default.
- W2886017639 countsByYear W28860176392021 @default.
- W2886017639 countsByYear W28860176392022 @default.
- W2886017639 countsByYear W28860176392023 @default.
- W2886017639 crossrefType "journal-article" @default.
- W2886017639 hasAuthorship W2886017639A5003983768 @default.
- W2886017639 hasAuthorship W2886017639A5010795152 @default.
- W2886017639 hasAuthorship W2886017639A5013394355 @default.
- W2886017639 hasAuthorship W2886017639A5029686578 @default.
- W2886017639 hasAuthorship W2886017639A5036480804 @default.
- W2886017639 hasAuthorship W2886017639A5044069348 @default.
- W2886017639 hasAuthorship W2886017639A5045576370 @default.
- W2886017639 hasAuthorship W2886017639A5061765670 @default.
- W2886017639 hasAuthorship W2886017639A5063697285 @default.